Cargando…
Adaptive sample size determination for the development of clinical prediction models
BACKGROUND: We suggest an adaptive sample size calculation method for developing clinical prediction models, in which model performance is monitored sequentially as new data comes in. METHODS: We illustrate the approach using data for the diagnosis of ovarian cancer (n = 5914, 33% event fraction) an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983402/ https://www.ncbi.nlm.nih.gov/pubmed/33745449 http://dx.doi.org/10.1186/s41512-021-00096-5 |
_version_ | 1783667898436288512 |
---|---|
author | Christodoulou, Evangelia van Smeden, Maarten Edlinger, Michael Timmerman, Dirk Wanitschek, Maria Steyerberg, Ewout W. Van Calster, Ben |
author_facet | Christodoulou, Evangelia van Smeden, Maarten Edlinger, Michael Timmerman, Dirk Wanitschek, Maria Steyerberg, Ewout W. Van Calster, Ben |
author_sort | Christodoulou, Evangelia |
collection | PubMed |
description | BACKGROUND: We suggest an adaptive sample size calculation method for developing clinical prediction models, in which model performance is monitored sequentially as new data comes in. METHODS: We illustrate the approach using data for the diagnosis of ovarian cancer (n = 5914, 33% event fraction) and obstructive coronary artery disease (CAD; n = 4888, 44% event fraction). We used logistic regression to develop a prediction model consisting only of a priori selected predictors and assumed linear relations for continuous predictors. We mimicked prospective patient recruitment by developing the model on 100 randomly selected patients, and we used bootstrapping to internally validate the model. We sequentially added 50 random new patients until we reached a sample size of 3000 and re-estimated model performance at each step. We examined the required sample size for satisfying the following stopping rule: obtaining a calibration slope ≥ 0.9 and optimism in the c-statistic (or AUC) < = 0.02 at two consecutive sample sizes. This procedure was repeated 500 times. We also investigated the impact of alternative modeling strategies: modeling nonlinear relations for continuous predictors and correcting for bias on the model estimates (Firth’s correction). RESULTS: Better discrimination was achieved in the ovarian cancer data (c-statistic 0.9 with 7 predictors) than in the CAD data (c-statistic 0.7 with 11 predictors). Adequate calibration and limited optimism in discrimination was achieved after a median of 450 patients (interquartile range 450–500) for the ovarian cancer data (22 events per parameter (EPP), 20–24) and 850 patients (750–900) for the CAD data (33 EPP, 30–35). A stricter criterion, requiring AUC optimism < = 0.01, was met with a median of 500 (23 EPP) and 1500 (59 EPP) patients, respectively. These sample sizes were much higher than the well-known 10 EPP rule of thumb and slightly higher than a recently published fixed sample size calculation method by Riley et al. Higher sample sizes were required when nonlinear relationships were modeled, and lower sample sizes when Firth’s correction was used. CONCLUSIONS: Adaptive sample size determination can be a useful supplement to fixed a priori sample size calculations, because it allows to tailor the sample size to the specific prediction modeling context in a dynamic fashion. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41512-021-00096-5. |
format | Online Article Text |
id | pubmed-7983402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79834022021-03-22 Adaptive sample size determination for the development of clinical prediction models Christodoulou, Evangelia van Smeden, Maarten Edlinger, Michael Timmerman, Dirk Wanitschek, Maria Steyerberg, Ewout W. Van Calster, Ben Diagn Progn Res Research BACKGROUND: We suggest an adaptive sample size calculation method for developing clinical prediction models, in which model performance is monitored sequentially as new data comes in. METHODS: We illustrate the approach using data for the diagnosis of ovarian cancer (n = 5914, 33% event fraction) and obstructive coronary artery disease (CAD; n = 4888, 44% event fraction). We used logistic regression to develop a prediction model consisting only of a priori selected predictors and assumed linear relations for continuous predictors. We mimicked prospective patient recruitment by developing the model on 100 randomly selected patients, and we used bootstrapping to internally validate the model. We sequentially added 50 random new patients until we reached a sample size of 3000 and re-estimated model performance at each step. We examined the required sample size for satisfying the following stopping rule: obtaining a calibration slope ≥ 0.9 and optimism in the c-statistic (or AUC) < = 0.02 at two consecutive sample sizes. This procedure was repeated 500 times. We also investigated the impact of alternative modeling strategies: modeling nonlinear relations for continuous predictors and correcting for bias on the model estimates (Firth’s correction). RESULTS: Better discrimination was achieved in the ovarian cancer data (c-statistic 0.9 with 7 predictors) than in the CAD data (c-statistic 0.7 with 11 predictors). Adequate calibration and limited optimism in discrimination was achieved after a median of 450 patients (interquartile range 450–500) for the ovarian cancer data (22 events per parameter (EPP), 20–24) and 850 patients (750–900) for the CAD data (33 EPP, 30–35). A stricter criterion, requiring AUC optimism < = 0.01, was met with a median of 500 (23 EPP) and 1500 (59 EPP) patients, respectively. These sample sizes were much higher than the well-known 10 EPP rule of thumb and slightly higher than a recently published fixed sample size calculation method by Riley et al. Higher sample sizes were required when nonlinear relationships were modeled, and lower sample sizes when Firth’s correction was used. CONCLUSIONS: Adaptive sample size determination can be a useful supplement to fixed a priori sample size calculations, because it allows to tailor the sample size to the specific prediction modeling context in a dynamic fashion. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41512-021-00096-5. BioMed Central 2021-03-22 /pmc/articles/PMC7983402/ /pubmed/33745449 http://dx.doi.org/10.1186/s41512-021-00096-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Christodoulou, Evangelia van Smeden, Maarten Edlinger, Michael Timmerman, Dirk Wanitschek, Maria Steyerberg, Ewout W. Van Calster, Ben Adaptive sample size determination for the development of clinical prediction models |
title | Adaptive sample size determination for the development of clinical prediction models |
title_full | Adaptive sample size determination for the development of clinical prediction models |
title_fullStr | Adaptive sample size determination for the development of clinical prediction models |
title_full_unstemmed | Adaptive sample size determination for the development of clinical prediction models |
title_short | Adaptive sample size determination for the development of clinical prediction models |
title_sort | adaptive sample size determination for the development of clinical prediction models |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983402/ https://www.ncbi.nlm.nih.gov/pubmed/33745449 http://dx.doi.org/10.1186/s41512-021-00096-5 |
work_keys_str_mv | AT christodoulouevangelia adaptivesamplesizedeterminationforthedevelopmentofclinicalpredictionmodels AT vansmedenmaarten adaptivesamplesizedeterminationforthedevelopmentofclinicalpredictionmodels AT edlingermichael adaptivesamplesizedeterminationforthedevelopmentofclinicalpredictionmodels AT timmermandirk adaptivesamplesizedeterminationforthedevelopmentofclinicalpredictionmodels AT wanitschekmaria adaptivesamplesizedeterminationforthedevelopmentofclinicalpredictionmodels AT steyerbergewoutw adaptivesamplesizedeterminationforthedevelopmentofclinicalpredictionmodels AT vancalsterben adaptivesamplesizedeterminationforthedevelopmentofclinicalpredictionmodels |